Cohance Lifesciences Ltd posted consolidated revenue of ₹5.45 billion and net profit of ₹367.2 million for the December quarter of FY26. The results highlight steady growth in the pharmaceutical and specialty chemicals sector, driven by operational efficiency, global demand, and strategic expansion into high-value life sciences segments.
Show moreStay Ahead – Explore Now! February 12 Nationwide Strike: SBI’s Contingency Plan In Motion
Updated: February 12, 2026 17:33
Updated: February 11, 2026 18:03
Updated: February 09, 2026 17:00
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
